[Luminal therapy in the prevention of icterus of the newborn caused by Rh incompatibility].
D001663:Bilirubin / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000201:enzymology; D004790:Enzyme Induction; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D007567:Jaundice, Neonatal / Q000517:prevention & control*; D007647:Kernicterus / Q000517:prevention & control*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D010634:Phenobarbital / Q000008:administration & dosage* / Q000494:pharmacology; D011247:Pregnancy; D011485:Protein Binding; D012204:Rh-Hr Blood-Group System; D012709:Serum Albumin
D012204:Rh-Hr Blood-Group System; D012709:Serum Albumin; D001663:Bilirubin; D010634:Phenobarbital
Die Luminal-Therapie und -Prophylaxe des durch Rhesusfaktor-Inkompatibilität hervorgerufenen ikterus der Neugeborenen.